EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSMMSG00000003804
Gene Symbol: PSMD8
1 Cross references
202 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSMMSG00000002294
Gene Symbol: PSMB11
1 Cross references
227 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSMMSG00000002569
Gene Symbol: PRMT5
1 Cross references
198 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSMMSG00000024088
Gene Symbol: PRKCA
1 Cross references
288 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSMMSG00000023580
Gene Symbol: PRKCB
1 Cross references
284 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSMMSG00000011239
Gene Symbol: PRKCD
1 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSMMSG00000010644
Gene Symbol: PRKCE
1 Cross references
316 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSMMSG00000009730
Gene Symbol: PRKCH
1 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSMMSG00000019029
Gene Symbol: PRKCG
1 Cross references
198 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSMMSG00000004250
Gene Symbol: PRKCI
1 Cross references
195 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSMMSG00000011467
Gene Symbol: PRKCQ
1 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSMMSG00000012075
Gene Symbol: PRKCZ
1 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).